Wells Fargo
VAXX

Wells Fargo’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Wells Fargo’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,731
Closed -$9.13K – 7703
2024
Q1 		$9.13K Buy
12,731
+1,704
+15% +$1.24K ﹤0.01% 5784
2023
Q4 		$9.37K Buy
11,027
+2,513
+30% +$2.43K ﹤0.01% 5853
2023
Q3 		$11.7K Sell
8,514
-9,223
-52% -$20K ﹤0.01% 5763
2023
Q2 		$44.7K Buy
17,737
+17,489
+7,052% +$37K ﹤0.01% 5465
2023
Q1 		$563 Buy
248
+4
+2% +$10 ﹤0.01% 6522
2022
Q4 		$342 Buy
244
+6
+3% +$10 ﹤0.01% 6484
2022
Q3 		$0 Buy
+238
New +$495 ﹤0.01% 7622

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Wells Fargo's VAXX Position: Q2 2024 in Review

Wells Fargo sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 12,731 shares — an estimated $9.13K sold.

Wells Fargo first reported a position in VAXX in Q3 2022 and held it in 7 quarters. The position peaked at $44.7K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Wells Fargo reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 12,731 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $9.13K.
  • Wells Fargo first reported a position in Vaxxinity, Inc. Class A Common Stock in Q3 2022 and held it in 7 quarters.
  • Wells Fargo's Vaxxinity, Inc. Class A Common Stock position peaked at $44.7K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.